Stay updated on Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T16:58:09.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T18:07:49.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record, with the 403 message shown near the top and site footer visible.
    Difference
    20%
    Check dated 2026-09-22T21:44:46.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    UI text for the contact information label is updated in capitalization, and a new Revision: v3.7.0 tag appears on the page.
    Difference
    0.1%
    Check dated 2026-09-15T21:55:53.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page's revision stamp was updated to v3.6.6, replacing the previous v3.6.5. This signals a new build/update of the page without altering its visible content or functionality.
    Difference
    0.0%
    Check dated 2026-09-01T18:56:08.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 with dates 2026-08-04, 2026-08-03, 2026-08 and 2027-07 was added, and the previous revision block v3.6.4 was removed. This reflects metadata or versioning updates rather than substantive changes to study information.
    Difference
    0.3%
    Check dated 2026-08-11T08:33:20.000Z thumbnail image

Stay in the know with updates to Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.